pentobarbital will decrease the extent or influence of fostemsavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.Keep track of Closely (two)pentobarbital will lower the level or outcome of suvorexant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Solid CYP3A4 inducers may perhaps reduce suvo